Thumbnail

Middle East & Africa Insulin Delivery Devices Market - Segmented by Type (Pens, Insulin Pumps, Insulin Syringes, Others) - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Looking to buy the report?

The market for insulin delivery devices is directly dependent on the increasing diabetic population. Middle East & African region has witnessed an astounding increase in the prevalence for diabetes in patients, in the resent years. In most of the countries in the region, the rate of diabetes has been at an all-time high, mainly due to the environmental and lifestyle changes. This has led to high sales of insulin’s in the region. Insulin was initially considered to the treatment method only for type 1 patients, but over the years insulin has also been used by considerable number of type 2 patients as a line of treatment. The Middle East & African market for insulin delivery devices is 810 million in 2018, and is expected to witness a CAGR of 2.79% during the forecast period.

The rising demand for insulin has led to tremendous R&D activities involving in manufacturing different painless types of insulin deliverable devices, like CGM integrated insulin pumps. Initially syringes were the only form of insulin delivery systems, which are considered to be painful and not user-friendly. Thus, the companies like Novo Nordisk, Sanofi among others, have produced their own insulin pens. These have a specific set dosage and are considered to be not only be less painful to use but also reduces wastage of insulin. The high cost of insulin pens is the only prominent restraining factor for the growth of the pens market.

A large set of the diabetic type 1 patients are children. There was a need for an alternative to the existing needle based delivery system which is painful. Thus, the invention of insulin jet injector, a painless insulin delivery system has come into picture. The insulin jet injector has registered high sales in developed countries, such as United States and Canada. These jet injectors are considered to be the future for insulin delivery system. The lack of awareness for the product and its benefits, when compare to conventional methods of insulin delivery acts as the prominent restrain for the product.  

Middle East & African region has a large number of diabetic population. Thus, the sales of insulin delivery devices is high in the region. Middle East & Africa accounts for close to 3.4% of the global market share of insulin delivery devices. In most of the Middle Eastern region, the consumer’s disposable income is high. Thus, the expenditure on the health care products is also high. The consumers in the region have high acceptance for new technology this is expected to boost the sales of jet injectors market during the forecast period. 

Source: Mordor Intelligence Analysis

Key Players:

Dexcom, Abbott, Johnson and Johnson, Ok biotech, Medtronic, Novo Nordisk, Insujet, Sanofi, Eli Lilly.

Key Developments:

Feb 2018: Dexcom Acquires TypeZero Technologies, paving the way for automated insulin delivery. The acquisition sends Dexcom on its way in the race to create an artificial pancreas system, rather than simply offering a continuous glucose monitoring device.

Report Scope:

Attribute

Details

Base year for estimation

2017

Review Period

2012-2017

Forecast Period

2018 – 2023

Market Representation

Revenue in USD million and CAGR from 2018 – 2023

Regions covered

Middle East

Report coverage

Revenue forecast and market dynamics

Reasons to Purchase this Report:

  • To study current and future of the market in the Middle East & Africa
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • Detailed analysis of the segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identifying the latest developments and strategies employed by the major market players
  • 3-month analyst support, along with the Market Estimate sheet (in Excel)

Report Customization and Benefits:

This report can be customized to meet the desired requirements. Please connect with our analyst, who will ensure that you get a report that suits your needs.

1. Introduction

                1.1 Scope of Study

                1.2 Market Definition

                1.3 Executive Summary

2. Research Methodology

                2.1 Study Deliverables

                2.2 Study Assumptions

                2.3 Research Phases

3. Market Insights

                3.1 Technology Trends

                3.2 Industry Attractiveness - Porter's Five Forces Analysis

                                3.2.1 Bargaining Power of the Suppliers

                                3.2.2 Bargaining Power of the Consumers

                                3.2.3 Threat of New Entrants

                                3.2.4 Threat of Substitute Products and Services

                                3.2.5 Competitive Rivalry within the Industry

4.  Market Dynamics

                4.1 Drivers

                4.2 Restraints

                4.3 Opportunities

5. Market Indicators

                5.1 Total Diabetes Population

                5.2 Type 1 Diabetes Population

                5.3 Type 2 Diabetes Population

6. Market Segmentation

                6.1 By Product

                                6.1.1 Reusable pens (cartridge)

                                                6.1.1.1 Reusable pens (cartridge), Revenue (2012-2023)

                                                6.1.1.2 Reusable pens (cartridge), Volume (2012-2023)

                                6.1.2 Disposable Pens

                                                6.1.2.1 Disposable Pens, Revenue (2012-2023)

                                                6.1.2.2 Disposable Pens, Volume (2012-2023)

                                6.1.3 Syringes

                                                6.1.3.1 Syringes, Revenue (2012-2023)

                                                6.1.3.2 Syringes, Volume (2012-2023)

                                6.1.4 Jet Injectors

                                                6.1.4.1 Syringes, Revenue (2012-2023)

                                                6.1.4.2 Syringes, Volume (2012-2023)

                                6.1.5 Insulin Pump

                                                6.1.5.1 Insulin Pump Device

                                                                6.1.5.1.1 Insulin Pump Devices, Revenue (2012-2023)

                                                                6.1.5.1.2 Insulin Pump Devices, Volume (2012-2023)

                                                6.1.5.2 Insulin Pump Reservoir

                                                                6.1.5.2.1 Insulin Pump Reservoirs, Revenue(2012-2023)

                                                                6.1.5.2.2 Insulin Pump Reservoirs, Volume(2012-2023)

                                                6.1.5.3 Infusion Set

                                                                6.1.5.3.1 Infusion Sets, Revenue (2012-2023)

                                                                6.1.5.3.2 Infusion Sets, Volume (2012-2023)

7. Geographical Analysis

                7.1Middle East & Africa

                                7.1.1 South Africa

                                                7.1.1.1 South Africa, Revenue (2012-2023)

                                                7.1.1.2 South Africa, Volume (2012-2023)

                                7.1.2 Saudi Arabia

                                                7.1.2.1 Saudi Arabia, Revenue (2012-2023)

                                                7.1.2.2 Saudi Arabia, Volume (2012-2023)

                                7.1.3 Oman

                                                7.1.3.1 Oman, Revenue (2012-2023)

                                                7.1.3.2 Oman, Volume (2012-2023)

                                7.1.4 Egypt

                                                7.1.4.1 Egypt, Revenue (2012-2023)

                                                7.1.4.2 Egypt, Volume (2012-2023)

                                7.1.5 Iran

                                                7.1.5.1 Iran, Revenue (2012-2023)

                                                7.1.5.2 Iran, Volume (2012-2023)

                                7.1.6 Rest of Middle East & Africa

                                                7.1.6.1 Rest of Middle East & Africa, Revenue (2012-2023)

                                                7.1.6.2 Rest of Middle East & Africa, Volume (2012-2023)

8. Company Profiles

                8.1 Becton and Dickenson

                8.2 Medtronic

                8.3 Insulet

                8.4 Roche

                8.5 Animas

                8.6 Tandem

                8.7 Ypsomed

                8.8 Abbott Diabetes Care

                8.9 Johnson & Johnson

                8.10 Novo Nordisk

                8.11 Sanofi

                8.12 Eli Lilly

                8.13 Dexcom

* Each Company Profile include overview, Revenue, Product and services, Swot, Recent Activities and strategic Analysis.

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy